Cancer immunotherapy, a treatment approach that has gained momentum over the past few years, only helps a small fraction of patients. But researchers from the Johns Hopkins University School of Medicine have developed a nanoparticle that may one day help expand the patient population that benefits from immunotherapy. Immunotherapy usually falls into 1 of 2 […]
Researchers from Johns Hopkins University have developed nanoparticles that can shuttle chemicals through the thick mucus membranes of pulmonary airways to deliver drugs. The team’s work was published in the journal Science Advances. Traditional therapies for cystic fibrosis, COPD and asthma include inhaled corticosteroids that adhere to the walls of air passages. Thick mucus tends to build […]
Johns Hopkins, the Maryland Stem Cell Research Fund and BioCardia (NSDQ:BCDA) said today that the 1st patient has been treated in a pivotal Phase III trial of the CardiAmp cell-based therapy for the treatment of ischemic heart failure. The investigational therapy was designed to deliver a dose of a patient’s own bone marrow cells directly […]
Researchers from Johns Hopkins University developed a coating made from antibiotic-releasing nanofibers to prevent bacterial infections related to total joint replacement surgery. The work was published this week in Proceedings of the National Academy of Science. Although the team used rodents’ knee joints to demonstrate the effects of the nanofiber film, they suggest that the coating […]
Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for arrhythmia, according to a press release from the Baltimore school. The work was published online yesterday in the Journal of Clinical Investigations and could 1 day be used […]
Johns Hopkins University said yesterday it is launching the EpiWatch patient data collection app for Apple‘s (NSDQ:AAPL) Apple Watch to collect data for patients with epilepsy before, during and after seizures. Data from the app will be used to analyze and better understand epilepsy, and to develop new methods for monitoring and managing the disease, […]
Johns Hopkins researchers reported what may be a major breakthrough in vision-saving medicine, creating a functioning "mini retina" made out of human stem cells.
MASSDEVICE ON CALL — U.S. Senate hopefuls vying for a seat in the Massachusetts campaign agree on 1 point: opposition to the medical device tax. Both Reps. Edward Markey (D) and private equity investor Gabriel Gomez (R) expressed disapproval of the 2.3% excise tax on medical device companies during the recent emphasis on tax policy on the campaign trial this week.